VRTX

NASDAQ:VRTX

Vertex Pharmaceuticals Incorporated

  • Stock

498.86

−2.09%

111.09

USD last updated 13/08 01:59:42

Last Close

387.77

12/08 21:12

Market Cap

126.86B

Beta: 0.49

Volume Today

1.45M

Avg: 1.12M

PE Ratio

31.95

PFCF: 26.33

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    12342017-01-252019-02-052021-02-012023-02-072024-08-01

    Revenue (Estimate*)

    1B2B3B4B2017-01-252019-02-052021-02-012023-02-072024-08-01

    *Estimate based on analyst consensus